ABOVE: © ISTOCK.COM, 13THREEPHOTOGRAPHY
Moncef Slaoui, the former head of the US government’s COVID-19 vaccine initiative called Operation Warp Speed, has been fired from the Galvani Bioelectronics Board of Directors following an investigation into sexual harassment allegations. GlaxoSmithKline, the British pharmaceutical company that jointly oversees Galvani and formerly employed Slaoui directly, received a complaint from an employee in February. According to a March 24 statement from the company, the investigation substantiated the claims and resulted in Slaoui’s dismissal as Galvani’s chair.
Slaoui led vaccine development at GSK until 2017. The letter sent by the victim to the GSK Board claimed that Slaoui engaged in harassing behavior many years ago during his tenure there. The company did not share specifics on the nature of the harassment or a narrower window on when it happened.
“Dr. Slaoui’s behaviours are wholly unacceptable. They represent an abuse of his leadership position, violate company policies, ...
